Phosphatidylinositol 3-kinase and prostaglandylinositol cyclic phosphate (cyclic PIP), a mediator of insulin action, in the signal transduction of insulin.

Autor: Gypakis A; Deutsches Diabetes-Forschungsinstitut, Abteilung für klinische Biochemie, Düsseldorf, Germany., Wasner HK
Jazyk: angličtina
Zdroj: Biological chemistry [Biol Chem] 2000 Nov; Vol. 381 (11), pp. 1139-41.
DOI: 10.1515/BC.2000.140
Abstrakt: It has been suggested that downstream signaling from the insulin receptor to the level of the protein kinases and protein phosphatases is accomplished by prosta-glandylinositol cyclic phosphate (cyclic PIP), a proposed second messenger of insulin. However, evidence points also to both phosphatidylinositol 3-kinase, which binds to the tyrosine phosphorylated insulin receptor substrate-1, and the Ras complex in insulin's downstream signaling. We have examined whether a correlation exists between these various observations. It was found that wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase, prevented insulin-induced, as well as cyclic PIP-induced activation of glucose transport, indicating that PI 3-kinase action on glucose transport involves downstream signaling of both insulin and cyclic PIP. Wortmannin has no effect on cyclic PIP synthase activity nor on the substrate production for cyclic PIP synthesis either, indicating that the functional role of PI 3-kinase is exclusively downstream of cyclic PIP.
Databáze: MEDLINE